- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Bajaj Healthcare received initial approval from the CDSCO's Subject Expert Committee to manufacture and market Cenobamate Tablets (a next-gen antiseizure medication). This makes BHL the first Indian company to secure this clearance, reinforcing its specialty pharma position.